Efficacy and safety of autologous adipose tissue-derived stem cell therapy for children with refractory Crohn's complex fistula: a Phase IV clinical study
CONCLUSION: ASC therapy is a simple and well-tolerated therapeutic option for children with refractory Crohn's complex fistulae. Complete closure was well-sustained. However, more data from a larger number of patients are needed.PMID:34235117 | PMC:PMC8255577 | DOI:10.4174/astr.2021.101.1.58
Source: Annals of Surgical Treatment and Research - Category: Surgery Authors: Yu Jeong Cho Hyunhee Kwon Yong Jae Kwon Kyung Mo Kim Seak Hee Oh Dae Yeon Kim Source Type: research
More News: Children | Crohn's Disease | Inflammatory Bowel Disease | Pediatrics | Stem Cell Therapy | Stem Cells | Study | Surgery